ZTS

Zoetis Inc (ZTS)

US
$ 159.27-1.5%

Price Chart

Key Statistics

Market Cap
$ 71.39B
P/E Ratio
28.74
Revenue (TTM)
$ 9.29B
Volume
4.22M
52W High
$ 200.33
52W Low
$ 139.70
Dividend Yield
1.29%
Beta
0.94

Technicals

50-Day MA
157.7328
200-Day MA
172.9263
52 Week High
200.33
52 Week Low
139.7

About ZTS

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision a.

Employees
13800
Headquarters
Parsippany, NJ
CEO
Ms. Kristin C. Peck

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score
28.6
Percentile: 49.38
Environmental Risk Score
2.72
Percentile: 1
Social Risk Score
13
Percentile: 1
Governance Risk Score
8.87
Percentile: 1

Controversy Level

ESG data provided by Sustainalytics, Inc.

ZTS
Category Average
1Low Controversy Level
NoneSevere

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg